Description
Idacio is a citrate-free adalimumab biosimilar biologic medicine manufactured by Fresenius Kabi. Delivered as a 40 mg/0.8 mL solution for subcutaneous injection, it is available in prefilled pen (auto-injector) and prefilled syringe formats. It is indicated for treating chronic inflammatory conditions such as Rheumatoid Arthritis, Psoriatic Arthritis, Crohn’s Disease, and Ulcerative Colitis, providing a highly similar alternative to the reference product Humira.
Best for
rheumatoid arthritis treatment, inflammatory bowel disease therapy, citrate-free injection preference and adalimumab biosimilar therapy